This suggests a mechanism to explain a decade of data demonstrating that σ2R/TMEM97 correlates with worse outcomes in a variety of solid tumors, including gastric (84), non–small cell lung (85, 86), squamous cell lung (87), and ovarian cancers (88). This evidence concerns the gene TMEM97 and ovarian cancer.